Showing 4,341 - 4,360 results of 11,397 for search 'significantly ((((lower decrease) OR (((we decrease) OR (mean decrease))))) OR (linear decrease))', query time: 0.42s Refine Results
  1. 4341

    Compounds of Type III Portland cement. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  2. 4342

    XXXX. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  3. 4343

    Impact test procedure on panel. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  4. 4344

    Summarized data of cost calculation. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  5. 4345

    Mixing and flow condition of REC15HDM. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  6. 4346

    External and internal view of the Omni mixer [ by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  7. 4347

    Required properties of sand. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  8. 4348

    Classification of panels after the impact test. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  9. 4349

    Static loading procedure. by Tek Raj Gyawali (20550560)

    Published 2025
    “…This enabled a reduction in fiber content to 1.2% (a 60% decrease) and panel thickness to 22 mm (a 4.35% decrease) compared to panels with thicker fibers. …”
  10. 4350

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  11. 4351

    Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

    Published 2025
    “…This study identified FHND5032, a novel small-molecule miR-124 inducer, as a potent therapeutic candidate for UC. We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …”
  12. 4352

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  13. 4353

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  14. 4354

    Primer pairs for RT-qPCR. by Yoichi Kurokawa (22290520)

    Published 2025
    “…Conversely, exposure to endogenous prooxidants (dopamine and adrenaline), certain food-derived polyphenols (chrysin and 3-<i><i>O</i></i>-methylquercetin), or 1,2-naphthoquinone led to a significant decrease (<0.5-fold) in Rmst expression. …”
  15. 4355

    RT-qPCR data tables. by Yoichi Kurokawa (22290520)

    Published 2025
    “…Conversely, exposure to endogenous prooxidants (dopamine and adrenaline), certain food-derived polyphenols (chrysin and 3-<i><i>O</i></i>-methylquercetin), or 1,2-naphthoquinone led to a significant decrease (<0.5-fold) in Rmst expression. …”
  16. 4356

    Specifications of prototypes of RSSCA system. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  17. 4357

    S1 Data - by Jessica C. M. Hui (20370522)

    Published 2024
    “…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”
  18. 4358

    Design of a RSSCA system for agriculture. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  19. 4359

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…<b>A33</b> significantly inhibited the proliferation, colony formation, migration, and invasion of PCa cells and induced substantial cell cycle arrest and apoptosis. …”
  20. 4360

    Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer by Jiaxing Li (113609)

    Published 2025
    “…<b>A33</b> significantly inhibited the proliferation, colony formation, migration, and invasion of PCa cells and induced substantial cell cycle arrest and apoptosis. …”